12122 Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices 

Dated: February 25, 2011. 

Thelma Sims, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2011–4944 Filed 3–3–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention—National Biosurveillance 

Advisory Sbcommittee (NBAS) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of 

aforementioned subcommittee: 

Time and Date: 8:30 a.m.–11:30 a.m., 

March 21, 2011. 

Place: Emory Conference Center Hotel, 

1615 Clifton Road, NE., Atlanta, Georgia 

30329, Telephone: (404) 712–6000. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 75 people. The 

public is welcome to participate during the 

public comment periods. The public 

comment period is tentatively scheduled for 

11 a.m.–11:15 a.m. 

Purpose: As a subcommittee to the CDC’s 

Advisory Committee to the Director (ACD), 

the NBAS will provide counsel to the CDC 

and the Federal government through the ACD 

regarding a broad range of human health 

surveillance issues arising from the 

development and implementation of a 

roadmap for the human health component of 

a national biosurveillance system. 

Matters to be Discussed: Agenda items will 

include the subcommittee’s discussion, 

deliberation, and vote on the proposed report 

for enhancing the nation’s biosurveillance 

capability. 

The agenda is subject to change as 

priorities dictate. 

Contact Person for More Information: 

Pamela Diaz, M.D., Designated Federal 

Officer, ACD, CDC—NBAS, 1600 Clifton 

Road, NE., M/S E–97, Atlanta, Georgia 30333. 

Telephone: (404) 498–0476. E-mail: 

pdiaz@cdc.gov. For security reasons, 

members of the public interested in attending 

the meeting should contact Mark Byers, 

Telephone: (404) 498–0481, E-mail: 

mbyers@cdc.gov. The deadline for 

notification of attendance is March 10, 2011. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 25, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–4994 Filed 3–3–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): The 

Association of Genetic Biomarkers and 

Hereditary Hemochromatosis, DD11– 

008, Initial Review 

Correction: This notice was published 

in the Federal Register on January 21, 

2011, Volume 76, Number 14, Page 

3908. The date for the aforementioned 

meeting has been changed to the 

following: 

DATES: April 26, 2011 (Closed) 

Contact Person for More Information: 

Michael Dalmat, Dr.P.H., Scientific 

Review Officer, CDC, National Center 

for Chronic Disease Prevention and 

Health Promotion, Office of the Director, 

Extramural Research Program Office, 

4770 Buford Highway, NE., Mailstop 

K–92, Atlanta, Georgia 30341, 

Telephone: (770) 488–6423, E-mail: 

MED1@CDC.GOV. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 25, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–4990 Filed 3–3–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier CMS–102 and CMS– 

105, and CMS–10241] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension without change of a 

currently approved collection; Title of 

Information Collection: Clinical 

Laboratory Improvement Amendments 

of 1988 (CLIA) Budget Workload 

Reports and Supporting Regulations in 

42 CFR 493.1–.2001; Use: The collected 

information will be used by CMS to 

determine the amount of Federal 

reimbursement for surveys conducted. 

Use of the information includes program 

evaluation, audit, budget formulation 

and budget approval. Form CMS–102 is 

a multi-purpose form designed to 

capture and record all budget and 

expenditure data. Form CMS–105 

captures the annual projected CLIA 

workload that the State survey agency 

will accomplish. It is also used by the 

CMS regional office to approve the 

annual projected CLIA workload. The 

information is required as part of the 

section 1864 agreement with the State; 

Form Numbers: CMS–102 and CMS–105 

(OMB#: 0938–0599); Frequency: 

Quarterly; Affected Public: State, Local, 

or Tribal Governments; Number of 

Respondents: 50; Total Annual 

Responses: 50; Total Annual Hours: 

4,500. (For policy questions regarding 


jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 43 / Friday, March 4, 2011 / Notices 12123 

this collection contact Carla Ausby at 

410–786–2153. For all other issues call 

410–786–1326.) 

2. Type of Information Collection 

Request: Extension without change of a 

currently approved collection; Title of 

Information Collection: Annual State 

Report and Annual State Performance 

Rankings; Use: Section 6001(f) of the 

Deficit Reduction Act (DRA) requires 

CMS to contract with a vendor to 

conduct a monthly national survey of 

retail prescription drug prices and to 

report the prices to the States. These 

national average prices may be used as 

a benchmark by the States for the 

management of their prescription drug 

programs. The DRA also requires that 

the States submit pricing information 

for the 50 most widely prescribed drugs 

so that the States’ prices can be 

compared to the national average prices 

obtained from the survey. The States 

pricing information will be compared 

and the States will be ranked. The Act 

also requires that States report their 

drug utilization rates for noninnovator 

multiple source (generic) drugs, their 

payment rates under their State plan, 

and their dispensing fees. The template 

has been developed to facilitate data 

collection; Form Number: CMS–10241 

(OMB#: 0938–1041); Frequency: Yearly; 

Affected Public: State, Local, or Tribal 

Governments; Number of Respondents: 

51; Total Annual Responses: 51; Total 

Annual Hours: 765. (For policy 

questions regarding this collection 

contact Joseph Fine at 410–786–2128. 

For all other issues call 410–786–1326.) 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS Web Site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

To be assured consideration, 

comments and recommendations for the 

proposed information collections must 

be received by the OMB desk officer at 

the address below, no later than 5 p.m. 

on April 14, 2011. 

OMB, Office of Information and 

Regulatory Affairs, Attention: CMS 

Desk Officer, Fax Number: (202) 395– 

6974, E-mail: 

OIRA_submission@omb.eop.gov. 

Dated: February 23, 2011. 

Martique Jones, 

Director, Regulations Development Group, 

Division B, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2011–4577 Filed 3–3–11; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Blood & Marrow Transplant Network Review 

Meeting. 

Date: March 28–29, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: ‘‘Courtyard’’ Crystal City—Marriott, 

2899 Jefferson Davis Highway, Arlington, VA 

22202. 

Contact Person: Keith A. Mintzer, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7186, 

Bethesda, MD 20892–7924, 301–435–0280, 

mintzerk@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Pediatric Heart Network Clinical Centers. 

Date: March 28–29, 2011. 

Time: 1 p.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Crystal City, 2799 

Jefferson Davis Highway, Arlington, VA 

22202. 

Contact Person: William J Johnson, PhD, 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, Room 

7178, Bethesda, MD 20892–7924, 301–435– 

0725, johnsonwj@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Conference Grant Review. 

Date: March 29–30, 2011. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting) 

Contact Person: Dana Phares, PhD, 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, Room 

7179, Bethesda, MD 20892–7924, 301–435– 

0310, pharesda@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: February 28, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–4943 Filed 3–3–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

Clinical Research. 

Date: March 22, 2011. 

Time: 8 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health/NCRR/ 

OR, Democracy I, 6701 Democracy Blvd., 

1078, Bethesda, MD (Virtual Meeting). 

Contact Person: Steven Birken, PhD, 

Scientific Review Officer, Office of Review, 

National Center for Research Resources, 

National Institutes of Health, 6701 

Democracy Blvd., 10th FL., Bethesda, MD 

20892, (301) 435–1078, 

birkens@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 


jlentini on DSKJ8SOYB1PROD with NOTICES